Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,245.50
-2.10 (-0.09%)
At close: Mar 2, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 926.95 billion as of March 2, 2026. Its market cap has decreased by -10.20% in one year.
Market Cap
926.95B
Enterprise Value
978.08B
Revenue
139.14B
Ranking
n/a
PE Ratio
51.97
Stock Price
2,245.50
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 926.95B, an increase of 62.69%. That is a compound annual growth rate of 18.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 926.95B | 2.23% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.70T |
| Cipla | 1.09T |
| Zydus Lifesciences | 927.45B |
| Aurobindo Pharma | 708.81B |
| Alkem Laboratories | 674.29B |
| Glenmark Pharmaceuticals | 602.98B |
| Laurus Labs | 580.78B |
| Ipca Laboratories | 387.89B |